MSB 1.29% $1.18 mesoblast limited

Crohn’s Disease, page-109

  1. 2,724 Posts.
    lightbulb Created with Sketch. 1810
    “So we are simply relying on the overview of results without actual data to rely on at the moment.Best case scenario it's an N of 12, and do you think we can safely draw definitive conclusions from an N of 12?”

    Actual holders of the stock are “we” . We rely on information released by the company.

    You are not a holder- You should only speak for yourself -
    You were wrong.
    You can tune in next Tuesday and find out the next update of Amy Lightner results- flagged to the market by the company.

    We - holders- are very intrigued- We are hopeful- we wait impatiently- we would love the same outcome of remission for all trial participants .

    But even if all patients were cured then there’s still a chance that it’s ………..

    a what ……. What would you insert then Stuffy?

    Enjoy your day- we look forward to hearing less from you

    You can safely draw the conclusion that I do speak for others

    Reg

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.18
Change
0.015(1.29%)
Mkt cap ! $1.347B
Open High Low Value Volume
$1.15 $1.20 $1.15 $4.551M 3.886M

Buyers (Bids)

No. Vol. Price($)
2 98246 $1.17
 

Sellers (Offers)

Price($) Vol. No.
$1.18 19079 2
View Market Depth
Last trade - 16.10pm 16/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.